Skip to main content
SpringerLink
Log in

Chronic graft-versus-host disease

  • Chapter
Bone Marrow Transplantation

Part of the book series: Cancer Treatment and Research ((CTAR,volume 50))

Abstract

Allogeneic marrow transplantation is an increasingly utilized treatment for life-threatening hematologic disorders. As results improve, the number of transplant centers has expanded to more than 200 institutions [1,2]. Utilization will continue to increase as the number of available marrow donors increases through selection of suitable HLA-nonidentical family or unrelated marrow donors [3–5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas ED. Marrow transplantation for malignant diseases (Karnofsky Memorial Lecture). J Clin Oncol 1983; 1:517–531.

    PubMed  CAS  Google Scholar 

  2. Bortin MM, Rimm AA. Increasing utilization of bone marrow transplantation. Transplantation 1986; 42:229–234.

    Article  PubMed  CAS  Google Scholar 

  3. Beatty PG, Clift RA, Mickelson EM, Nisperos B, Flournoy N, Martin PJ, Sanders JE, Storb R, Thomas ED, Hansen JA. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313:765–771.

    Article  PubMed  CAS  Google Scholar 

  4. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980; 303:565–567.

    Article  PubMed  CAS  Google Scholar 

  5. Beatty PG, Dahlberg S, Mickelson EM, Nisperos B, Opelz G, Martin PJ, Hansen JA. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45:714–718.

    Article  PubMed  CAS  Google Scholar 

  6. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K, Gallucci B, Thomas ED, Storb R. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978; 92:545–570.

    Google Scholar 

  7. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB. Scleroderma, Sjögren-like syndrome and chronic graft-versus-host disease. Ann Intern Med 1977; 87: 707–709.

    PubMed  CAS  Google Scholar 

  8. Graze PR, Gale RP. Chronic graft versus host disease: A syndrome of disordered immunity. Am J Med 1979; 66:611–619.

    Article  PubMed  CAS  Google Scholar 

  9. Billingham RE. The biology of graft-versus-host reactions. Harvey Lectures 1966; 62: 21–78.

    PubMed  Google Scholar 

  10. Tsoi M-S. Immunologic mechanisms of graft-versus-host disease in man. Transplantation 1982; 33:459–464.

    Article  PubMed  CAS  Google Scholar 

  11. Sullivan KM. Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986; 4(Suppl l):42–93.

    Article  PubMed  Google Scholar 

  12. Martin PJ, Hansen JA, Storb R, Thomas ED. Human marrow transplantation: An immunological perspective. In: Advances in Immunology, Vol 40, Dixon FJ, ed. Academic Press, Orlando, 1987:379–438.

    Chapter  Google Scholar 

  13. Vogelsang GB, Hess AD, Berkman AW, Tutschka PJ, Farmer ER, Converse PJ, Santos GW. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med 1985; 313:645–650.

    Article  PubMed  CAS  Google Scholar 

  14. Bagot M, Cordonnier C, Heslan M. A possible predictive test for graft-versus-host disease in bone marrow graft recipients: The mixed epidermal cell lymphocyte reaction. Transplantation 1986; 41:316–319.

    Article  PubMed  CAS  Google Scholar 

  15. Lonnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G. Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation 1984; 38:465–468.

    Article  PubMed  CAS  Google Scholar 

  16. Jacobsen N, Andersen HK, Skinhoj P, Ryder LP, Platz P, Jerne D, Faber V, for the Copenhagen Bone Marrow Transplantation Group. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Scand J Haematol 1986; 36:499–506.

    Article  PubMed  CAS  Google Scholar 

  17. Bostrom L, Ringden O, Gratama JW, Jacobsen N, Zwaan F, Nilsson B, for the Leukaemia Working Party of the Euro Group for Bone Marrow Transplantation. Herpes virus and graft-versus-host disease: A European multicenter trial. Exp Hematol 1989; 17:656a.

    Google Scholar 

  18. van Bekkum DW, Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977; 58:787–789.

    PubMed  Google Scholar 

  19. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: Beneficial effect of a protective environment. N Engl J Med 1983; 308:302–307.

    Article  PubMed  CAS  Google Scholar 

  20. Winston DJ, Ho WG, Lin C-H, Bartoni K, Budinger MD, Gale RP, Champlin RE. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 1987; 106:12–18.

    PubMed  CAS  Google Scholar 

  21. Atkinson K, Farewell V, Storb R, Tsoi M-S, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED. Analysis of late infections after human bone marrow trans-plantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982; 60:714–720.

    PubMed  CAS  Google Scholar 

  22. Tutschka PJ, Teasdall R, Beschorner WE, Santos GW. Chronic graft-versus-host disease in the rat radiation chimera: II. Immunological evaluation in long term chimeras. Transplantation 1982; 34:289–294.

    Article  PubMed  CAS  Google Scholar 

  23. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi M-S, Storb R, Thomas ED. Chronic graft-versus-host syndrome in man: A long-term clinicopathological study of 20 Seattle patients. Am J Med 1980; 69:204–217.

    Article  PubMed  CAS  Google Scholar 

  24. Atkinson K, Incefy GS, Storb R, Sullivan KM, Iwata T, Dardenne M, Ochs HD, Good RA, Thomas ED. Low serum thymic hormone levels in patients with chronic graft-versus-host disease. Blood 1982; 59:1073–1077.

    PubMed  CAS  Google Scholar 

  25. Hess AD, Vogelsang GB, Heyd J, et al. Cyclosporine-induced syngeneic graft-versus-host disease: Assessment of T-cell differentiation. Transplant Proc 1987; 19:2683–2686.

    PubMed  CAS  Google Scholar 

  26. Thein SL, Goldman JM, Galton DAG. Acute “graft-versus-host disease” after autografting for chronic granulocytic leukemia in transformation. Ann Intern Med 1981; 94:210–211.

    PubMed  CAS  Google Scholar 

  27. Parkman R. Clonal analysis of murine graft-versus-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. J Immunol 1986; 136:3543–3548.

    PubMed  CAS  Google Scholar 

  28. Cohen J. Cytokines as mediators of graft-versus-host disease. Bone Marrow Transplantation 1988;3:193–197.

    PubMed  CAS  Google Scholar 

  29. Niederwieser D, Aubock J, Hajek-Rosenmayr A, Schonitzer D, Schendl D, Huber CH. The role of cytokines and MHC antigens in human GVHD: Analysis of T-cell specificities and endogenous cytokine levels. Bone Marrow Transplantation 1989; 4(Suppl 2):84–85.

    Google Scholar 

  30. Piguet P-F, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachetin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease. J Exp Med 1987; 166: 1280–1289.

    Article  PubMed  CAS  Google Scholar 

  31. Sale GE, Shulman HM, Schubert MM, Sullivan KM, Kopecky KJ, Hackman RC, Morton TH, Storb R, Thomas ED. Oral and ophthalmic pathology of graft versus host disease in man: Predictive value of the lip biopsy. Hum Pathol 1981; 12:1022–1030.

    Article  PubMed  CAS  Google Scholar 

  32. Beschorner WE, Tutschka PJ, Santos GW. Chronic graft-versus-host disease in the rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras. Transplantation 1982; 33:393–399.

    Article  PubMed  CAS  Google Scholar 

  33. McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 1981; 80:914–921.

    PubMed  CAS  Google Scholar 

  34. Stein-Streilein J, Lipscomb MF, Hart DA, Darden A. Graft-versus-host reaction in the lung. Transplantation 1981; 32:38–44.

    Article  PubMed  CAS  Google Scholar 

  35. Beschorner WE, Sarai R, Hutchins GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone marrow transplants. N Engl J Med 1978; 299:1030–1036.

    Article  PubMed  CAS  Google Scholar 

  36. O’Brien KD, Hackman RC, Sale GE, Prentice R, Deeg J, Thomas ED, Storb R. Lymphocytic bronchitis unrelated to acute graft-versus-host disease in canine marrow graft recipients. Transplantation 1984; 37:233–238.

    Article  PubMed  Google Scholar 

  37. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107:648–656.

    PubMed  CAS  Google Scholar 

  38. Holland HK, Wingard JR, Beschorner WE, Sarai R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72:621–627.

    PubMed  CAS  Google Scholar 

  39. Izutsu KT, Sullivan KM, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Rice JC, Witherspoon RP, Storb R, Thomas ED. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 1983; 35:441–446.

    Article  PubMed  CAS  Google Scholar 

  40. Smith CIE, Aarli JA, Biberfeld P, Bolme P, Christensson B, Gahrton G, Hammarstrom L, Lefvert AK, Lonnqvist B, Matell G, Pirskanen R, Ringden O, Svanborg E. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin. N Engl J Med 1983; 309:1565–1568.

    Article  PubMed  CAS  Google Scholar 

  41. Bolger GB, Sullivan KM, Spence AM, Appelbaum FR, Johnston R, Sanders JE, Deeg HJ, Witherspoon RP, Doney KC, Nims J, Thomas ED, Storb R. Myasthenia gravis after allogeneic bone marrow transplantation: Relationship to chronic graft-versus-host disease. Neurology 1986; 36:1087–1091.

    PubMed  CAS  Google Scholar 

  42. Reyes MG, Noronha P, Thomas W, Heredia R. Myositis of chronic graft-versus-host disease. Neurology 1983; 33:1222–1224.

    PubMed  CAS  Google Scholar 

  43. Shulman HM, Sullivan KM. Graft-versus-host disease: Allo-and autoimmunity after bone marrow transplantation. In: Concepts in Immunopathology: Cellular Aspects of Autoimmunity, Vol 6, Cruse J, Lewis RE Jr, eds. Karger, Basel, 1988:141–165.

    Google Scholar 

  44. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57:267–276.

    PubMed  CAS  Google Scholar 

  45. Weiner RS and Advisory Board of the International Bone Marrow Transplant Registry (IBMTR). Bone marrow transplantation (BMT) for leukemia: Time windows of complications. Exp Hematol 1989; 17:580a.

    Google Scholar 

  46. Klingemann H-G, Storb R, Fefer A, Deeg HJ, Appelbaum FR, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, Witherspoon RP, Thomas ED. Bone marrow transplantation in patients 45 years and older. Blood 1986; 67:770–776.

    PubMed  CAS  Google Scholar 

  47. Niederwieser D, Pepe M, Storb R, Witherspoon R, Longton G, Sullivan K. Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplant 1989; 4:151–156.

    PubMed  CAS  Google Scholar 

  48. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FA, Sanders JE, Stewart PS, Thomas ED. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98:461–466.

    PubMed  CAS  Google Scholar 

  49. Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P, Sanders J, Meyers JD, Martin PJ, Doney KC, Deeg HJ, Clift RA, Buckner CD, Appelbaum FR, Thomas ED. Second marrow infusion for poor graft function following allogeneic marrow transplantation. Bone Marrow Transplant 1986; 1:21–30.

    PubMed  CAS  Google Scholar 

  50. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153:478–488.

    Article  PubMed  CAS  Google Scholar 

  51. Miller W, Flynn P, McCullough J, Balfour HH, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J. Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-versus-host disease. Blood 1986; 67:1162–1167.

    PubMed  CAS  Google Scholar 

  52. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, Deeg HJ, Sanders JE, Doney KC, Appelbaum FR, McGuffin R, McDonald GB, Meyers J, Schubert MM, Gauvreau J, Shulman HM, Sale GE, Anasetti C, Loughran TP, Strom S, Nims J, Thomas ED. Prednisone and azathioprine compared to prednisone and placebo for treatment of chronic graft-versus-host disease: Prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72:546–554.

    PubMed  CAS  Google Scholar 

  53. Loughran TP, Sullivan KM, Morton T, Beckham C, Schubert M, Witherspoon RP, Sale G, Sanders JE, Fisher LD, Shulman H, Thomas ED, Storb R. Value of day 100 studies for predicting the development of chronic graft-versus-host disease following allogeneic bone marrow transplantation, submitted for publication.

    Google Scholar 

  54. Izutsu KT, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Ensign WY, Mersai T, Sullivan KM, Oberg S, Thomas ED. The predictive value of elevated labial saliva sodium concentration: Its relation to labial gland pathology in bone marrow transplant recipients. Hum Pathol 1983; 14:29–35.

    Article  PubMed  CAS  Google Scholar 

  55. Repetto M, Bacigalupo A, Viale M, et al. Cytochemical analysis of peripheral blood mono-nuclear cells following allogeneic bone marrow transplantation: Correlation of hydrolase expression with graft-versus-host disease. Blood 1985; 66:1011–1016.

    PubMed  CAS  Google Scholar 

  56. Vogelsang GB, Pardoll D, Taylor S, Simons J, Wingard J, Santos, G, Hess AD. T-cell receptors (TCR) in chronic graft-versus-host disease (GVHD). Exp Hematol 1989; 17: 654a.

    Google Scholar 

  57. Furst DE, Clements PJ, Graze P, Gale R, Roberts N. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: A model for scleroderma? Arthritis Rheum 1979; 22:904–910.

    Article  CAS  Google Scholar 

  58. Sullivan KM, Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clin Haematol 1983; 12:775–789.

    PubMed  CAS  Google Scholar 

  59. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Gastroenterology 1986; 90:460–477;

    PubMed  CAS  Google Scholar 

  60. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Gastroenterology 1986; 90:770–784.

    PubMed  CAS  Google Scholar 

  61. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, Truelove EL, Sale GE, Buckner CD, Storb R, Thomas ED. Oral manifestations of chronic graft-host disease. Arch Intern Med 1984; 144:1591–1595.

    Article  PubMed  CAS  Google Scholar 

  62. Jack MK, Jack GM, Sale GE, Shulman HM, Sullivan KM. Ocular manifestations of graft-v-host disease. Arch Ophthalmol 1983; 101:1080–1084.

    PubMed  CAS  Google Scholar 

  63. Corson SL, Sullivan K, Batzer F, August C, Storb R, Thomas ED. Gynecologic manifestations of chronic graft-versus-host disease. Obstet Gynecol 1982; 60:488–492.

    PubMed  CAS  Google Scholar 

  64. Schubert MA, Sullivan KM, Schubert MM, Nims J, Hansen M, Sanders JE, O’Quigley J, Witherspoon RP, Buckner CD, Storb R, Thomas ED. Gynecologic abnormalities following allogeneic bone marrow transplantation. Submitted for publication.

    Google Scholar 

  65. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappaport JM. Isolated thrombocytopenia after allogeneic bone marrow transplant and chronic thrombocytopenic syndromes. Blood 1985; 65:368–374.

    PubMed  CAS  Google Scholar 

  66. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73:1054–1058.

    PubMed  CAS  Google Scholar 

  67. Witherspoon RP. Suppression and recovery of immunologic function after bone marrow transplantation. J Natl Cancer Inst 1986; 76:1321–1324.

    PubMed  CAS  Google Scholar 

  68. Lum LG. A review: The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69:369–380.

    PubMed  CAS  Google Scholar 

  69. Lapp WS, Ghayur T, Mendes M, Seddik M, Seemayer TA. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev 1985; 88:107–133.

    Article  PubMed  CAS  Google Scholar 

  70. Beschorner WE, Tutschka PJ, Santos GW. Chronic graft-versus-host disease in the rat radiation chimera. III. Immunology and immunopathology in rapidly induced models. Transplantation 1983; 35:224–230.

    Article  PubMed  CAS  Google Scholar 

  71. Sullivan KM. Intravenous immune globulin prophylaxis in marrow transplant recipients. J Allergy Clin Immunol, 1989; 84:632–639.

    Article  PubMed  CAS  Google Scholar 

  72. Winston DJ, Schiffman G, Wang DC, Feig S, Lin CH, Marso EL, Ho WG, Young LS, Gale RP. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 1979; 91:835–841.

    PubMed  CAS  Google Scholar 

  73. Kalhs P, Panzer S, Kletter K, Minar E, Stain-Kos M, Walter R, Lechner K, Hinterberger W. Functional asplenia after bone marrow transplantation: A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med 1988; 109:461–464.

    PubMed  CAS  Google Scholar 

  74. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, Noel D, Thomas ED. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53:720–731.

    PubMed  CAS  Google Scholar 

  75. Gingrich RD, Ginder GD, Goeken NE, Howe CWS, Wen B-C, Hussey DH, Fyfe MA. Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood 1988;71:1375–1381.

    PubMed  CAS  Google Scholar 

  76. Loughran TP, Sullivan KM. Early detection and monitoring of chronic graft-versus-host disease. In: Graft-Versus-Host Disease, Burakoff SJ, Deeg HJ, Ferrara JLM, Atkinson K, eds. Marcel Dekker, New York, in press.

    Google Scholar 

  77. McDonald GB, Sullivan KM, Plumley TF. Radiographic features of esophageal involvement in chronic graft-vs-host disease. Am J Roent 1984; 142:501–506.

    CAS  Google Scholar 

  78. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation. N Engl J Med 1975; 292:832–843.

    Article  PubMed  CAS  Google Scholar 

  79. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD. Bone-marrow transplantation. N Engl J Med 1975; 292:895–902.

    Article  PubMed  CAS  Google Scholar 

  80. Atkinson, K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM, for the Advisory Committee of the International Bone Marrow Transplant Registry. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4:247–254.

    PubMed  CAS  Google Scholar 

  81. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin S, Beschorner WE, Cahill RA, Miller DF, Harrison D, Sarai R, Santos GW. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428–1435.

    PubMed  CAS  Google Scholar 

  82. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Ann Intern Med 1989; 111:368–376.

    PubMed  CAS  Google Scholar 

  83. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffman RG, Kay HEM, Kersey JH, Marmont A, Masaoka T, Rimm AA, van Rood JJ, Zwaan FE. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397–406.

    Article  PubMed  CAS  Google Scholar 

  84. Atkinson K, Storb R, Ochs HD, Goehle S, Sullivan KM, Witherspoon RP, Lum LG, Tsoi M-S, Sanders JE, Parr M, Stewart P, Thomas ED. Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. Transplantation 1982; 33:168–173.

    Article  PubMed  CAS  Google Scholar 

  85. Witherspoon RP, Sullivan KM, Lum LG, Goehle S, Atkinson K, Ochs HD, Doney K, Hansen JA, Sanders J, Storb R. Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: Brief report with 2 to 12 years’ follow-up. Bone Marrow Transplant 1988; 3:425–435.

    PubMed  CAS  Google Scholar 

  86. Sullivan KM. Immunoglobulin therapy in bone marrow transplantation. Am J Med 1987; 83:34–45.

    Article  PubMed  CAS  Google Scholar 

  87. Petersen FB, Bowden RA, Thornquist M, Meyers JD, Buckner CD, Counts GW, Nelson N, Newton BA, Sullivan KM, McIver J, Thomas ED. The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. Bone Marrow Transplant 1987; 2:141–148.

    PubMed  CAS  Google Scholar 

  88. Graham-Pole J, Camitta B, Casper J, Elfenbein G, Gross S, Herzig R, Koch P, Mahoney D, Marcus R, Munoz L, Pick T, Spruce W, Steuber P, Weiner R. Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: A Pediatric Oncology Group study. Bone Marrow Transplant 1988; 3:559–566.

    CAS  Google Scholar 

  89. Sullivan KM, Kopecky K, Jocom J, Buckner CD, Counts G, Meyers JD, Petersen FB, Bowden R, Witherspoon RP, Storb R, Thomas ED. Antimicrobial and immunomodulatory effects of intravenous immunoglobulin in bone marrow transplantation. Blood 1988; 72:410a.

    Google Scholar 

  90. Sullivan KM, Deeg HJ, Sanders J, Klosterman A, Amos D, Shulman H, Sale G, Martin P, Witherspoon R, Appelbaum FR, Doney K, Stewart P, Meyers J, McDonald GB, Weiden P, Fefer A, Buckner CD, Storb R, Thomas ED. Hyperacute GVHD in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986; 67:1172–1175.

    PubMed  CAS  Google Scholar 

  91. Vogelsang GB, Hess AD, Gordon G, Santos GW. Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model. Transplantation 1986; 41:644–647.

    Article  PubMed  CAS  Google Scholar 

  92. Storb R, Deeg HJ, Fisher LD, Appelbaum F, Buckner CD, Bensinger W, Clift R, Doney K, Irle C, McGuffin R, Martin P, Sanders J, Schoch G, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED. Cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia: Long-term follow-up of three controlled trials. Blood 1988; 71:293–298.

    PubMed  CAS  Google Scholar 

  93. Storb R, Deeg HJ, Pepe M, Appelbaum FR, Anasetti C, Beatty P, Bensinger W, Berenson R, Buckner CD, Clift R, Doney K, Longton G, Hansen J, Hill R, Loughran TP, Martin P, Singer J, Sanders J, Stewart P, Sullivan KM, Witherspoon R, Thomas ED. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 1989; 73:1729–1734.

    PubMed  CAS  Google Scholar 

  94. Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Anasetti C, Appelbaum FR, Beatty P, Buckner CD, Deeg HJ, Doney K, Fisher L, Loughran TP, Martin P, Meyers J, McDonald GB, Sanders J, Shulman HM, Stewart P, Thomas ED. Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia. Clin Transplantation 1989; 3:5–11.

    Google Scholar 

  95. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, Loughran TP, Hill R, Shields A, Yee G, Shulman H, Nims J, Strom S, Thomas ED. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood 1988; 72:555–561.

    PubMed  CAS  Google Scholar 

  96. Schubert MM, Sullivan KM. Recognition, incidence and management of oral graft-versus-host disease. J Natl Cane Inst, in press.

    Google Scholar 

  97. Sullivan KM, Meyers JD, Flournoy N, Storb R, Thomas ED. Early and late interstitial pneumonia following human bone marrow transplantation. Int J Cell Cloning 1986; 4 (Suppl 1):107–121.

    Article  PubMed  Google Scholar 

  98. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979; 300:1068–1073.

    Article  PubMed  CAS  Google Scholar 

  99. Ringden O, Horowitz MM, for the Advisory Committee of the International Bone Marrow Transplant Registry. Graft-versus-leukemia reactions in humans. Transplant Proc 1989; 21:2989–2992.

    PubMed  CAS  Google Scholar 

  100. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED, the Seattle Marrow Transplant Team. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304:1529–1533.

    Article  PubMed  CAS  Google Scholar 

  101. Sanders JE, Flournoy N, Thomas ED, Buckner CD, Lum LG, Clift RA, Appelbaum FR, Sullivan KM, Stewart P, Deeg HJ, Doney K, Storb R. Marrow transplant experience in children with acute lymphoblastic leukemia: An analysis of factors associated with survival, relapse and graft-versus-host disease. Med Pediatr Oncol 1985; 13:165–172.

    Article  PubMed  CAS  Google Scholar 

  102. Weisdorf DJ, Nesbit ME, Ramsay NKC, Woods WG, Goldman AI, Kim TH, Hurd DD, McGlave PB, Kersey JH. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: Prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5:1348–1355.

    PubMed  CAS  Google Scholar 

  103. Sullivan KM, Fefer A, Witherspoon R, Storb R, Buckner CD, Weiden P, Schoch G, Thomas ED. Graft-versus-leukemia in man: Relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. In: Cellular Immunotherapy of Cancer, Proceedings of the International Symposium on Cellular Immunotherapy of Cancer, Truitt RL, Gale RP, Bortin MM, eds. Alan R Liss, New York, 1987:391–399.

    Google Scholar 

  104. Odom LF, August CS, Githens JH, Humbert JR. ‘Graft-versus-leukemia’ reaction following bone marrow transplantation for acute lymphoblastic leukemia. In: Graft-Versus Leukemia in Man and Animal Models, O’Kunewick JP, Meredith RF, eds. CRC Press, Boca Raton, FL, 1981:25.

    Google Scholar 

  105. Sullivan KM, Shulman HM. Chronic graft-versus-host disease, obliterative bronchiolitis and graft-versus-leukemia effect: Case histories. Transplant Proc 1989; 21:51–62.

    PubMed  CAS  Google Scholar 

  106. Higano CS, Brixey M, Bryant EM, Durnam DM, Doney K, Sullivan KM, Singer JW. Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation: A case report of a graft-versus-leukemia effect. Transplantation, in press.

    Google Scholar 

  107. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, Kennedy MS, Sullivan KM, Flournoy N, Storb R, Thomas ED. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66:664–672.

    PubMed  CAS  Google Scholar 

  108. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73:1720–1728.

    PubMed  CAS  Google Scholar 

  109. Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas ED. Graft-versus host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med 1989; 320:828–834.

    Article  PubMed  CAS  Google Scholar 

  110. Sullivan KM, Deeg HJ, Sanders JE, Shulman HM, Witherspoon RP, Doney K, Appelbaum FR, Schubert MM, Stewart P, Springmeyer S, McDonald GB, Storb R, Thomas ED. Late complications after marrow transplantation. Semin Hematol 1984; 21:53–63.

    PubMed  CAS  Google Scholar 

  111. Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, Deeg HJ, Storb R, Thomas ED. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983; 36:252–255.

    Article  PubMed  CAS  Google Scholar 

  112. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR, Storb R, Thomas ED. Growth and development following marrow transplantation for leukemia. Blood 1986; 68:1129–1135.

    PubMed  CAS  Google Scholar 

  113. Schmidt GM, Fonbuena PP, Chao NJ, Stallbaum BA, Barr TA, Blume KG, Forman SJ. ‘Quality of life’ in survivors of allogeneic bone marrow transplantation (MBT) for malignant disease. Psychosoc Aspects Cancer 1989; 8:311.

    Google Scholar 

  114. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED. Secondary malignancies following marrow transplantation for aplastic anemia. N Engl J Med 1989; 321:784–789.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Keith M. Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. MD Anderson Cancer Center, Houston, Texas, USA

    Richard Champlin M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Sullivan, K.M. (1990). Chronic graft-versus-host disease. In: Champlin, R. (eds) Bone Marrow Transplantation. Cancer Treatment and Research, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1493-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1493-6_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8803-9

  • Online ISBN: 978-1-4613-1493-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation